These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 35075553)
21. Potential role of lipoxin in the management of COVID-19: a narrative review. Batiha GE; Al-Gareeb AI; Elekhnawy E; Al-Kuraishy HM Inflammopharmacology; 2022 Dec; 30(6):1993-2001. PubMed ID: 36114383 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic/Pharmacodynamic Modeling of Dexamethasone Anti-Inflammatory and Immunomodulatory Effects in LPS-Challenged Rats: A Model for Cytokine Release Syndrome. Świerczek A; Jusko WJ J Pharmacol Exp Ther; 2023 Mar; 384(3):455-472. PubMed ID: 36631280 [TBL] [Abstract][Full Text] [Related]
23. RS-5645 attenuates inflammatory cytokine storm induced by SARS-CoV-2 spike protein and LPS by modulating pulmonary microbiota. Liu T; Wu J; Han C; Gong Z; Regina G; Chen J; Dou F; Silvestri R; Chen C; Yu Z Int J Biol Sci; 2021; 17(13):3305-3319. PubMed ID: 34512148 [TBL] [Abstract][Full Text] [Related]
24. Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis. Kamel NA; Ismail NSM; Yahia IS; Aboshanab KM Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056328 [TBL] [Abstract][Full Text] [Related]
25. Phenylmethimazole is a candidate drug for the treatment of severe forms of coronavirus disease 2019 (COVID-19) as well as other virus-induced "cytokines storm". Giuliani C; Bucci I; Napolitano G Med Hypotheses; 2021 Jan; 146():110473. PubMed ID: 33385879 [TBL] [Abstract][Full Text] [Related]
26. The Efficacy and Safety of Imusil® Tablets in the Treatment of Adult Patients With Mild COVID-19: A Prospective, Randomized, Multicenter, Open-Label Study. Abhyankar M; Kadam D; Reddy PR; Siddiqui MZ; Ratheesh M; Jagmag T; Tilwani J Cureus; 2023 Mar; 15(3):e35881. PubMed ID: 37051002 [TBL] [Abstract][Full Text] [Related]
27. Melatonin interferes with COVID-19 at several distinct ROS-related steps. Camp OG; Bai D; Gonullu DC; Nayak N; Abu-Soud HM J Inorg Biochem; 2021 Oct; 223():111546. PubMed ID: 34304092 [TBL] [Abstract][Full Text] [Related]
28. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748 [TBL] [Abstract][Full Text] [Related]
29. The Efficacy of Traditional Medicinal Plants in Modulating the Main Protease of SARS-CoV-2 and Cytokine Storm. Choe J; Har Yong P; Xiang Ng Z Chem Biodivers; 2022 Nov; 19(11):e202200655. PubMed ID: 36125969 [TBL] [Abstract][Full Text] [Related]
30. Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications. Ong WY; Go ML; Wang DY; Cheah IK; Halliwell B Mol Neurobiol; 2021 Jan; 58(1):106-117. PubMed ID: 32897518 [TBL] [Abstract][Full Text] [Related]
31. Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management. Anka AU; Tahir MI; Abubakar SD; Alsabbagh M; Zian Z; Hamedifar H; Sabzevari A; Azizi G Scand J Immunol; 2021 Apr; 93(4):e12998. PubMed ID: 33190302 [TBL] [Abstract][Full Text] [Related]
32. Vathasura Kudineer, an Andrographis based polyherbal formulation exhibits immunomodulation and inhibits chikungunya virus (CHIKV) under invitro conditions. Hasan A; Devi Ms S; Sharma G; Narayanan V; Sathiyarajeswaran P; Vinayak S; Sunil S J Ethnopharmacol; 2023 Feb; 302(Pt A):115762. PubMed ID: 36181982 [TBL] [Abstract][Full Text] [Related]
34. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review. Quirch M; Lee J; Rehman S J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537 [TBL] [Abstract][Full Text] [Related]
35. The Potential Effect of Dapsone on the Inflammatory Reactions in COVID-19: Staggering View. Al-Kuraishy HM; Al-Gareeb AI; Elekhnawy E; Alexiou A; Batiha GE Comb Chem High Throughput Screen; 2024; 27(5):674-678. PubMed ID: 36999691 [TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2-mediated liver injury: pathophysiology and mechanisms of disease. Choaib A; Issa E; El Choueiry F; Eldin JN; Shbaklo K; Alhajj M; Sawaya RT; Assi G; Nader M; Chatila R; Faour WH Inflamm Res; 2023 Feb; 72(2):301-312. PubMed ID: 36539655 [TBL] [Abstract][Full Text] [Related]
37. Peramivir, an Anti-Influenza Virus Drug, Exhibits Potential Anti-Cytokine Storm Effects. Zhang CX; Tu Y; Sun XC; Chen DG; Zhang WN; Zhuang CL; Wang ZB; Su L Front Immunol; 2022; 13():856327. PubMed ID: 35296098 [TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR. Shakeeb N; Varkey P; Hynse A; Mandlecha A Inflammopharmacology; 2022 Jun; 30(3):883-894. PubMed ID: 35320494 [TBL] [Abstract][Full Text] [Related]
39. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy. Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D Cells; 2021 Dec; 11(1):. PubMed ID: 35011614 [TBL] [Abstract][Full Text] [Related]
40. Perilla (Perilla frutescens) leaf extract inhibits SARS-CoV-2 via direct virus inactivation. Tang WF; Tsai HP; Chang YH; Chang TY; Hsieh CF; Lin CY; Lin GH; Chen YL; Jheng JR; Liu PC; Yang CM; Chin YF; Chen CC; Kau JH; Hung YJ; Hsieh PS; Horng JT Biomed J; 2021 Jun; 44(3):293-303. PubMed ID: 34119448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]